Baudax Bio Statistics Share Statistics Baudax Bio has 0
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 43.59M Failed to Deliver (FTD) Shares 13,831 FTD / Avg. Volume 3.26%
Short Selling Information Short Interest n/a Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) n/a
Valuation Ratios The PE ratio is -0.02 and the forward
PE ratio is null.
Baudax Bio's PEG ratio is
0.
PE Ratio -0.02 Forward PE n/a PS Ratio 0.83 Forward PS n/a PB Ratio -0.04 P/FCF Ratio -0.04 PEG Ratio 0
Financial Ratio History Enterprise Valuation Baudax Bio has an Enterprise Value (EV) of 2.91M.
EV / Sales 2.3 EV / EBITDA -0.08 EV / EBIT -0.1 EV / FCF -0.1
Financial Position The company has a current ratio of 0.3,
with a Debt / Equity ratio of -0.29.
Current Ratio 0.3 Quick Ratio 0.3 Debt / Equity -0.29 Debt / EBITDA -0.2 Debt / FCF -0.26 Interest Coverage -1.7
Financial Efficiency Return on Equity is 242.53% and Return on Invested Capital is 208.74%.
Return on Equity 242.53% Return on Assets -586.07% Return on Invested Capital 208.74% Revenue Per Employee $141K Profits Per Employee $-6.53M Employee Count 9 Asset Turnover 0.13 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 17.65% in the
last 52 weeks. The beta is 1.58, so Baudax Bio's
price volatility has been higher than the market average.
Beta 1.58 52-Week Price Change 17.65% 50-Day Moving Average 0.02 200-Day Moving Average 0.27 Relative Strength Index (RSI) 47.49 Average Volume (20 Days) 424,847
Income Statement In the last 12 months, Baudax Bio had revenue of 1.27M
and earned -58.8M
in profits. Earnings per share was -177.3.
Revenue 1.27M Gross Profit -5.74M Operating Income -35.74M Net Income -58.8M EBITDA -35.58M EBIT -37.73M Earnings Per Share (EPS) -177.3
Full Income Statement Balance Sheet The company has 5.26M in cash and 7.12M in
debt, giving a net cash position of -1.86M.
Cash & Cash Equivalents 5.26M Total Debt 7.12M Net Cash -1.86M Retained Earnings -190.9M Total Assets 20.58M Working Capital -17.71M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -27.79M
and capital expenditures -20K, giving a free cash flow of -27.81M.
Operating Cash Flow -27.79M Capital Expenditures -20K Free Cash Flow -27.81M FCF Per Share -83.87
Full Cash Flow Statement Margins Gross margin is -452.32%, with operating and profit margins of -2816.63% and -4633.18%.
Gross Margin -452.32% Operating Margin -2816.63% Pretax Margin -4633.18% Profit Margin -4633.18% EBITDA Margin -2803.62% EBIT Margin -2816.63% FCF Margin -2191.73%
Dividends & Yields BXRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield -5575.44% FCF Yield -2637.46%
Dividend Details Analyst Forecast Currently there are no analyst rating for BXRX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 1, 2022. It was a
backward
split with a ratio of 1:40.
Last Split Date Dec 1, 2022 Split Type backward Split Ratio 1:40
Scores Altman Z-Score -15.9 Piotroski F-Score 1
